Impacting T-cell fitness in multiple myeloma: potential roles for selinexor and XPO1 inhibitors
Binder, Adam F, Walker, Christopher J, Mark, Tomer M, Baljevic, Muhamed
Published in Frontiers in immunology (26.10.2023)
Published in Frontiers in immunology (26.10.2023)
Get full text
Journal Article
Harnessing the T Cell to Treat Multiple Myeloma: Dawn of a New Therapeutic Paradigm
Keller, Alana L, Sherbenou, Daniel W, Forsberg, Peter A, Mark, Tomer M
Published in Frontiers in oncology (24.06.2022)
Published in Frontiers in oncology (24.06.2022)
Get full text
Journal Article
Daratumumab, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma: subgroup analysis of CASTOR based on cytogenetic risk
Weisel, Katja, Spencer, Andrew, Lentzsch, Suzanne, Avet-Loiseau, Hervé, Mark, Tomer M, Spicka, Ivan, Masszi, Tamas, Lauri, Birgitta, Levin, Mark-David, Bosi, Alberto, Hungria, Vania, Cavo, Michele, Lee, Je-Jung, Nooka, Ajay, Quach, Hang, Munder, Markus, Lee, Cindy, Barreto, Wolney, Corradini, Paolo, Min, Chang-Ki, Chanan-Khan, Asher A, Horvath, Noemi, Capra, Marcelo, Beksac, Meral, Ovilla, Roberto, Jo, Jae-Cheol, Shin, Ho-Jin, Sonneveld, Pieter, Casneuf, Tineke, DeAngelis, Nikki, Amin, Himal, Ukropec, Jon, Kobos, Rachel, Mateos, Maria-Victoria
Published in Journal of hematology and oncology (20.08.2020)
Published in Journal of hematology and oncology (20.08.2020)
Get full text
Journal Article
309 MYC Inhibition Overcomes IMiD Resistance in Heterogeneous Multiple Myeloma Populations
Davis, Lorraine, Walker, Zachary J., Ohlstrom, Denis, Stevens, Brett M., Forsberg, Peter A., Mark, Tomer M., Jordan, Craig T., Sherbenou, Daniel W.
Published in Journal of clinical and translational science (01.04.2022)
Published in Journal of clinical and translational science (01.04.2022)
Get full text
Journal Article
Overcoming the response plateau in multiple myeloma: a novel bortezomib-based strategy for secondary induction and high-yield CD34+ stem cell mobilization
Niesvizky, Ruben, Mark, Tomer M, Ward, Maureen, Jayabalan, David S, Pearse, Roger N, Manco, Megan, Stern, Jessica, Christos, Paul J, Mathews, Lena, Shore, Tsiporah B, Zafar, Faiza, Pekle, Karen, Xiang, Zhaoying, Ely, Scott, Skerret, Donna, Chen-Kiang, Selina, Coleman, Morton, Lane, Maureen E
Published in Clinical cancer research (15.03.2013)
Published in Clinical cancer research (15.03.2013)
Get full text
Journal Article
Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma
Palumbo, Antonio, Chanan-Khan, Asher, Weisel, Katja, Nooka, Ajay K, Masszi, Tamas, Beksac, Meral, Spicka, Ivan, Hungria, Vania, Munder, Markus, Mateos, Maria V, Mark, Tomer M, Qi, Ming, Schecter, Jordan, Amin, Himal, Qin, Xiang, Deraedt, William, Ahmadi, Tahamtan, Spencer, Andrew, Sonneveld, Pieter
Published in The New England journal of medicine (25.08.2016)
Published in The New England journal of medicine (25.08.2016)
Get full text
Journal Article
Overall Survival With Daratumumab, Bortezomib, and Dexamethasone in Previously Treated Multiple Myeloma (CASTOR): A Randomized, Open-Label, Phase III Trial
Sonneveld, Pieter, Chanan-Khan, Asher, Weisel, Katja, Nooka, Ajay K, Masszi, Tamas, Beksac, Meral, Spicka, Ivan, Hungria, Vania, Munder, Markus, Mateos, Maria-Victoria, Mark, Tomer M, Levin, Mark-David, Ahmadi, Tahamtan, Qin, Xiang, Garvin Mayo, Wendy, Gai, Xue, Carey, Jodi, Carson, Robin, Spencer, Andrew
Published in Journal of clinical oncology (10.03.2023)
Published in Journal of clinical oncology (10.03.2023)
Get full text
Journal Article
Monoclonal Antibodies in Multiple Myeloma: A New Wave of the Future
Sherbenou, Daniel W., Mark, Tomer M., Forsberg, Peter
Published in Clinical lymphoma, myeloma and leukemia (01.09.2017)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2017)
Get full text
Journal Article
Health‐related quality of life maintained over time in patients with relapsed or refractory multiple myeloma treated with daratumumab in combination with bortezomib and dexamethasone: results from the phase III CASTOR trial
Hungria, Vania, Beksac, Meral, Weisel, Katja C., Nooka, Ajay K., Masszi, Tamas, Spicka, Ivan, Munder, Markus, Mateos, María‐Victoria, Mark, Tomer M., Qi, Ming, Qin, Xiang, Fastenau, John, Spencer, Andrew, Sonneveld, Pieter, Garvin, Wendy, Renaud, Thomas, Gries, Katharine S.
Published in British journal of haematology (01.05.2021)
Published in British journal of haematology (01.05.2021)
Get full text
Journal Article
Results of an early access treatment protocol of daratumumab in United States patients with relapsed or refractory multiple myeloma
Chari, Ajai, Lonial, Sagar, Mark, Tomer M., Krishnan, Amrita Y., Stockerl‐Goldstein, Keith E., Usmani, Saad Z., Londhe, Anil, Etheredge, Delores, Fleming, Sarah, Liu, Baolian, Ukropec, Jon, Lin, Thomas S., Jagannath, Sundar, Nooka, Ajay K.
Published in Cancer (15.11.2018)
Published in Cancer (15.11.2018)
Get full text
Journal Article
Hispanics have the lowest stem cell transplant utilization rate for autologous hematopoietic cell transplantation for multiple myeloma in the United States: A CIBMTR report
Schriber, Jeffrey R., Hari, Parameswaran N., Ahn, Kwang Woo, Fei, Mingwei, Costa, Luciano J., Kharfan‐Dabaja, Mohamad A., Angel‐Diaz, Miguel, Gale, Robert P., Ganguly, Siddharatha, Girnius, Saulius K., Hashmi, Shahrukh, Pawarode, Attaphol, Vesole, David H., Wiernik, Peter H., Wirk, Baldeep M., Marks, David I., Nishihori, Taiga, Olsson, Richard F., Usmani, Saad Z., Mark, Tomer M., Nieto, Yago L., D'Souza, Anita
Published in Cancer (15.08.2017)
Published in Cancer (15.08.2017)
Get full text
Journal Article
High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma
Gomez-Arteaga, Alexandra, Mark, Tomer M., Guarneri, Danielle, Christos, Paul J., Gergis, Usama, Greenberg, June D., Hsu, Jingmei, Mayer, Sebastian A., Niesvizky, Ruben, Pearse, Roger N., Phillips, Adrienne A., Rossi, Adriana, Coleman, Morton, van Besien, Koen, Shore, Tsiporah B.
Published in Bone marrow transplantation (Basingstoke) (01.12.2019)
Published in Bone marrow transplantation (Basingstoke) (01.12.2019)
Get full text
Journal Article
Exploiting Protein Translation Dependence in Multiple Myeloma with Omacetaxine-Based Therapy
Walker, Zachary J, Idler, Beau M, Davis, Lorraine N, Stevens, Brett M, VanWyngarden, Michael J, Ohlstrom, Denis, Bearrows, Shelby C, Hammes, Andrew, Smith, Clayton A, Jordan, Craig T, Mark, Tomer M, Forsberg, Peter A, Sherbenou, Daniel W
Published in Clinical cancer research (01.02.2021)
Published in Clinical cancer research (01.02.2021)
Get full text
Journal Article
Pomalidomide: New immunomodulatory agent with potent antiproliferative effects
Richardson, Paul G, Mark, Tomer M, Lacy, Martha Q
Published in Critical reviews in oncology/hematology (01.10.2013)
Published in Critical reviews in oncology/hematology (01.10.2013)
Get full text
Journal Article